The COMET Study is the nation’s first prospective, randomized clinical trial aimed at resolving an ongoing debate about the best way to manage “low-risk” DCIS (Ductal Carcinoma In Situ), also known as “stage zero” breast cancer. “This is a trial whose time has come. Many of us have felt for two decades that this study … Continue reading What is “Low-risk” DCIS & Why is The COMET Study Urgently Needed?